Sherwin-Williams director granted 558 RSUs

THAMAN MICHAEL H reported acquisition or exercise transactions in this Form 4 filing.

Accepted by SEC EDGAR 02/17/2026 - 06:18 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

THAMAN MICHAEL H reported acquisition or exercise transactions in this Form 4 filing.

Sherwin-Williams director Michael H. Thaman reported an award of 558 restricted stock units, each representing one share of Common Stock, granted at $0 under the 2025 Equity and Incentive Compensation Plan. The RSUs vest in three annual installments starting on February 16, 2027. After this grant, he beneficially owns 8,111 shares and RSUs directly and 5,480.97 deferred stock units indirectly through the 2005 Director Deferred Fee Plan.

Insider Trade Summary

Grant/Award: 558 shares

Grant/Award 1 txn

Insider THAMAN MICHAEL H

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	558	$0.00	$0.00
Holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 8,111 shares (Direct); Common Stock — 5,480.97 shares (Indirect, Deferred Fee Plan)

Footnotes (4)

1. F1. Grant of restricted stock units ("RSUs"), pursuant to the terms of an RSU agreement under The Sherwin-Williams Company 2025 Equity and Incentive Compensation Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock. The RSUs vest annually in three substantially equal installments commencing February 16, 2027.
2. F2. These securities consist of 1,100 RSUs and 7,011 shares of Common Stock.
3. F3. No transaction is being reported on this line. Reported on a previously filed Form 4.
4. F4. These securities consist of deferred stock units, held pursuant to the 2005 Director Deferred Fee Plan, and include deferred stock units acquired pursuant to the dividend reinvestment feature of such Plan.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Sherwin-Williams (SHW) director Michael H. Thaman report?

Michael H. Thaman reported receiving 558 restricted stock units in Sherwin-Williams Common Stock. The units were granted at a price of $0 under the company’s 2025 Equity and Incentive Compensation Plan and represent a stock-based compensation award, not an open-market purchase.

How many Sherwin-Williams (SHW) RSUs did Michael H. Thaman receive and when do they vest?

He received 558 restricted stock units, each equal to one Sherwin-Williams share. These RSUs vest in three substantially equal annual installments, with vesting commencing on February 16, 2027, according to the terms of the RSU agreement under the 2025 Equity and Incentive Compensation Plan.

What is Michael H. Thaman’s Sherwin-Williams (SHW) share ownership after this Form 4?

Following the reported award, he beneficially owns 8,111 Sherwin-Williams shares and RSUs directly. In addition, he has 5,480.97 deferred stock units held indirectly through the 2005 Director Deferred Fee Plan, which includes units acquired via the plan’s dividend reinvestment feature.

What is the Sherwin-Williams (SHW) 2025 Equity and Incentive Compensation Plan mentioned in the filing?

The 2025 Equity and Incentive Compensation Plan is the program under which Thaman’s 558 restricted stock units were granted. Each RSU under this plan entitles the reporting person to receive one share of Sherwin-Williams Common Stock, subject to the plan’s vesting schedule and other terms.

What is the Sherwin-Williams (SHW) 2005 Director Deferred Fee Plan referenced in the Form 4?

The 2005 Director Deferred Fee Plan holds Thaman’s 5,480.97 deferred stock units. These units include those acquired through the plan’s dividend reinvestment feature, allowing director compensation and related amounts to be deferred into stock-based units rather than taken as immediate cash payments.

Does the Sherwin-Williams (SHW) Form 4 report any open-market stock purchases or sales?

The Form 4 reports a grant or award of 558 restricted stock units at $0, coded as an acquisition (A). Footnotes clarify the award is part of an equity compensation plan, and no open-market purchase or sale transaction is reported in this filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

THAMAN MICHAEL H

(Last) (First) (Middle)

1 SHERWIN WAY

(Street)

CLEVELAND OH 44113

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SHERWIN WILLIAMS CO [ SHW ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/17/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/17/2026		A		558(1)	A	$0	8,111(2)	D
Common Stock(3)								5,480.97(4)	I	Deferred Fee Plan

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of restricted stock units ("RSUs"), pursuant to the terms of an RSU agreement under The Sherwin-Williams Company 2025 Equity and Incentive Compensation Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock. The RSUs vest annually in three substantially equal installments commencing February 16, 2027.

2. These securities consist of 1,100 RSUs and 7,011 shares of Common Stock.

3. No transaction is being reported on this line. Reported on a previously filed Form 4.

4. These securities consist of deferred stock units, held pursuant to the 2005 Director Deferred Fee Plan, and include deferred stock units acquired pursuant to the dividend reinvestment feature of such Plan.

Remarks:

	Stephen J. Perisutti, Attorney-in-fact	02/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.